US 12,033,733 B2
Storage and dispensing devices for administration of oral transmucosal dosage forms
Andrew Poutiatine, Mill Valley, CA (US); Bruce Edwards, Menlo Park, CA (US); Charles Rampersaud, Castro Valley, CA (US); Pamela Palmer, San Francisco, CA (US); Bradley Blackwood, San Jose, CA (US); and Benjamin K. Yaffe, San Franciso, CA (US)
Assigned to Vertical Pharmaceuticals, LLC, Alpharetta, GA (US)
Filed by Vertical Pharmaceuticals, LLC, Alpharetta, GA (US)
Filed on May 1, 2023, as Appl. No. 18/141,689.
Application 15/292,909 is a division of application No. 14/041,963, filed on Sep. 30, 2013, abandoned.
Application 14/041,963 is a division of application No. 12/724,634, filed on Mar. 16, 2010, granted, now 8,548,623, issued on Oct. 1, 2013.
Application 18/141,689 is a continuation of application No. 17/150,450, filed on Jan. 15, 2021, granted, now 11,676,691.
Application 17/150,450 is a continuation of application No. 16/143,046, filed on Sep. 26, 2018, granted, now 10,896,751, issued on Jan. 9, 2021.
Application 16/143,046 is a continuation of application No. 15/292,909, filed on Oct. 13, 2016, abandoned.
Claims priority of provisional application 61/161,267, filed on Mar. 18, 2009.
Prior Publication US 2023/0260612 A1, Aug. 17, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. G16H 10/65 (2018.01); A61J 7/00 (2006.01); A61J 7/04 (2006.01); G06K 19/077 (2006.01); G16H 20/13 (2018.01); G16Z 99/00 (2019.01); H04B 5/77 (2024.01)
CPC G16H 10/65 (2018.01) [A61J 7/0053 (2013.01); A61J 7/0418 (2015.05); A61J 7/0436 (2015.05); A61J 7/0445 (2015.05); A61J 7/0463 (2015.05); G06K 19/07762 (2013.01); G06K 19/07783 (2013.01); G16H 20/13 (2018.01); G16Z 99/00 (2019.02); H04B 5/77 (2024.01); A61J 2200/30 (2013.01); A61J 2205/50 (2013.01); A61J 2205/60 (2013.01)] 11 Claims
OG exemplary drawing
 
1. An apparatus, comprising:
a housing defining an actuation pathway and a channel in communication with the actuation pathway;
a delivery member, at least a portion of the delivery member being disposed within the actuation pathway such that a distal end portion of the delivery member and a distal end portion of the housing define a volume configured to contain a drug-containing tablet, the delivery member configured to move relative to the housing in a distal direction to expel the drug-containing tablet from the volume, the delivery member including a protrusion configured to engage a portion of the housing to limit movement of the delivery member relative to the housing in a proximal direction, the delivery member including an elongate protrusion slidably disposed within the channel, an edge of the elongate protrusion configured to limit movement of the delivery member relative to the housing in the distal direction; and
the housing includes a bridge configured to engage the delivery member, at least a portion of the bridge configured to be separated from the housing when the delivery member is moved relative to the housing in the distal direction.